Skip to main content

T82.838D vs Z93

T82.838D (Hemorrhage due to vascular prosthetic devices, implants and grafts, subsequent encounter) compared with Z93 (Artificial opening status), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).

Relationship

Informational

Excludes2 relationship

T82.838D
Hemorrhage due to vascular prosthetic devices, implants and grafts, subsequent encounter
Z93
Artificial opening status

Distinct conditions — both may be reported.

“artificial opening status (Z93.-)”

An Excludes2 note means the excluded condition is not part of the code above it, but a patient can have both. Report both when both are documented.

Source: CMS ICD-10-CM tabular instructional notes

Can these codes be reported together?

Yes, when both are documented. T82.838D carries an Excludes2 note covering Z93: “artificial opening status (Z93.-)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Side by side

T82.838DHemorrhage due to vascular prosthetic devices, implants and grafts, subsequent encounterZ93Artificial opening status
Billing statusBillableNon-billable header

Report instead: Z93.0, Z93.1, Z93.2, Z93.3, Z93.4

ClassificationS00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)
DefinitionHemorrhage due to vascular prosthetic devices, implants and grafts, subsequent encounter is a billable ICD-10-CM diagnosis code (T82.838D).Artificial opening status is a non-billable ICD-10-CM category code (Z93).
7th characterThe appropriate 7th character is to be added to each code from category T82
Use additional code
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
code(s) to identify the specified condition resulting from the complication
code to identify devices involved and details of circumstances (Y62-Y82)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources